PPJ Healthcare Enterprises, Inc. (PPJE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
PPJE Revenue
PPJ Healthcare Enterprises had revenue of $211.60K in the quarter ending March 31, 2012, a decrease of -5.01%. This brings the company's revenue in the last twelve months to $787.22K, up 324.47% year-over-year. In the year 2011, PPJ Healthcare Enterprises had annual revenue of $906.05K with 134.48% growth.
Revenue (ttm)
787.22K
Revenue Growth
+324.47%
P/S Ratio
0.01
Revenue / Employee
787.22K
Employees
1
Market Cap
9.21K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2011 | 906.05K | 519.64K | 134.48% |
| Dec 31, 2010 | 386.41K | 234.41K | 154.22% |
| Dec 31, 2009 | 152.00K | 49.00K | 47.57% |
| Dec 31, 2008 | 103.00K | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 2.61M |